What is Hangzhou Tigermed Consulting Co Dividend Payout Ratio?
Hangzhou Tigermed Consulting Co's dividend payout ratio for the
months ended in Dec. 2023 was 0.00.
The historical rank and industry rank for Hangzhou Tigermed Consulting Co's Dividend Payout Ratio or its related term are showing as below:
SZSE:300347'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.21 Med: 0.31 Max: 0.64
Current: 0.28
During the past 13 years, the highest Dividend Payout Ratio of Hangzhou Tigermed Consulting Co was 0.64. The lowest was 0.21. And the median was 0.31.
As of today (2024-04-24), the Dividend Yield % of Hangzhou Tigermed Consulting Co is 1.04%.
During the past 13 years, the highest Trailing Annual Dividend Yield of Hangzhou Tigermed Consulting Co was 1.43%. The lowest was 0.14%. And the median was 0.43%.
Hangzhou Tigermed Consulting Co's Dividends per Share for the
months ended in Dec. 2023 was ¥0.00.
During the past 12 months, Hangzhou Tigermed Consulting Co's average Dividends Per Share Growth Rate was 10.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 25.50% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 31.10% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 22.50% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Hangzhou Tigermed Consulting Co was 60.70% per year. The lowest was -20.40% per year. And the median was 30.05% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Hangzhou Tigermed Consulting Co Dividend Payout Ratio Historical Data
The historical data trend for Hangzhou Tigermed Consulting Co's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hangzhou Tigermed Consulting Co Dividend Payout Ratio Chart
|
Hangzhou Tigermed Consulting Co Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Dividend Payout Ratio |
|
Get a 7-Day Free Trial
|
|
|
0.31 |
0.31 |
0.21 |
0.28 |
0.32 |
|
Hangzhou Tigermed Consulting Co Quarterly Data
|
|
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Dividend Payout Ratio |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
- |
0.91 |
- |
- |
Competitive Comparison of Hangzhou Tigermed Consulting Co's Dividend Payout Ratio
For the Diagnostics & Research subindustry, Hangzhou Tigermed Consulting Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hangzhou Tigermed Consulting Co's Dividend Payout Ratio Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Hangzhou Tigermed Consulting Co's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Hangzhou Tigermed Consulting Co's Dividend Payout Ratio falls into.
Hangzhou Tigermed Consulting Co Dividend Payout Ratio Calculation
Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.
Hangzhou Tigermed Consulting Co's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as
Hangzhou Tigermed Consulting Co's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hangzhou Tigermed Consulting Co (SZSE:300347) Business Description
Traded in Other Exchanges
Address
Block 8, No. 19 Jugong Road, Room 2001-2010, 20th Floor, Xixing Sub-District, Binjiang District, Hangzhou, CHN, 310053
Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's segment includes Clinical trial solutions and Clinical-related and laboratory services. It generates maximum revenue from the Clinical trial solutions segment. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.
Hangzhou Tigermed Consulting Co (SZSE:300347) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:300347 has been successfully added to your